Home > Boards > US OTC > Biotechs > Vitro Diagnostics, Inc. (VODG)

JonesBur...results timetable, filing delinquency.....

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Potse Member Profile
Followed By 34
Posts 497
Boards Moderated 0
Alias Born 03/19/09
160x600 placeholder
Potse   Wednesday, 01/23/19 04:18:57 PM
Re: JonesBur post# 2281
Post # of 2302 
JonesBur...results timetable, filing delinquency.....

Agree with most, but to say the 2018 results will be released soon is stretching the definition. In the past, they have provided a yearly update as soon as December, but as late as September.

I still expect the FY 2018 press release will be issued fairly soon. Starting with the FY 2017 results (fiscal year ends in October), VODG has been consistently producing a financial results press release roughly 2 months after the respective financial period.

So I was anticipating seeing the PR come out sometime in early January (factoring in the hectic nature of the holidays). So basically, as it stands right now, the PR is only about 2 weeks "overdue" based on my personal timetable. Maybe they have decided to go to a more conventional 3-month schedule.

Lastly, 100% agree with the filing delinquency here. Without getting official, the pps won't see any sustained increase as nobody can believe any of their numbers.

I have no reason to doubt the accuracy/integrity of the financial numbers that VODG reports in its results press releases. I'm quite confident there will be no noticeable difference in the numbers if/when VODG begins resuming its SEC filings (other than higher expenses associated with audits, SEC filings, etc, of course).

My primary/paramount concern with VODG is making sure the stock doesn't get suspended/revoked because of that filing delinquency. It is incredibly risky to be delinquent as long as VODG has been. Suspended/revoked stocks are like feathers-in-the-cap for people in the SEC. It helps justify their continued employment and continued flow of money into their departments.

It is of utmost importance that VODG gets the filing situation resolved and its OTC profile updated on OTC Markets. The risk/reward for both current and potential investors would be dramatically improved if this issue was not overhanging the stock.

That is why I want to see management express/convey a sense of urgency on issue, or provide a detailed explanation of why VODG investors should not be overly concerned about this particular issue. Hopefully the upcoming press release will provide some insight on this.


Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
Current Price
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist